International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device (ADMIRE-ICD)
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Sponsor: ABX CRO
Terminated
Sponsor discretion (low recruitment rate)
Other terminated trials from ABX CRO
More terminations from ABX CRO
Other Heart Failure trials with similar outcome
This PHASE3 trial investigates Heart Failure and is currently terminated or withdrawn. ABX CRO leads this study, which shows 19 recorded versions since 2015 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
19 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE3
▶ Show 14 earlier versions
-
Aug 2019 — Jan 2021 [monthly]
Terminated PHASE3
-
Jun 2019 — Aug 2019 [monthly]
Terminated PHASE3
Status: Suspended → Terminated
-
Jun 2018 — Jun 2019 [monthly]
Suspended PHASE3
-
Apr 2018 — Jun 2018 [monthly]
Suspended PHASE3
Status: Recruiting → Suspended
-
Feb 2018 — Apr 2018 [monthly]
Recruiting PHASE3
-
Dec 2017 — Feb 2018 [monthly]
Recruiting PHASE3
-
Oct 2017 — Dec 2017 [monthly]
Recruiting PHASE3
-
Aug 2017 — Oct 2017 [monthly]
Recruiting PHASE3
-
Jul 2017 — Aug 2017 [monthly]
Recruiting PHASE3
-
Jun 2017 — Jul 2017 [monthly]
Recruiting PHASE3
-
Apr 2017 — Jun 2017 [monthly]
Recruiting PHASE3
-
Mar 2017 — Apr 2017 [monthly]
Recruiting PHASE3
-
Feb 2017 — Mar 2017 [monthly]
Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE3
First recorded
Dec 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- ABX CRO
- AG Mednet Inc.
- Advanced Clinical, LLC
- GE Healthcare
- H2O Clinical LLC
- ICON CEAC
- ICON Clinical
- TFS
- TransPerfect
For direct contact, visit the study record on ClinicalTrials.gov .